Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Sep 7, 2028 (in 694 days)
Similar opportunities open now
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)Same funderOpenNational Institutes of HealthCloses Oct 2027
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Jan 7, 2027 (in 85 days)
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)Same funderOpenNational Institutes of HealthCloses Oct 2027
- Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 2027
Classification and identifiers
- Solicitation number
- PA-25-253
- Assistance listing (CFDA)
- 93.399
Amount
Amount not listed here. Check the official program.
Who can apply
Local government agencies, Nonprofits, including small and volunteer-run organizations, and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).